Airrane Co., Ltd. (KOSDAQ:163280)
17,740
-250 (-1.39%)
At close: Aug 6, 2025, 3:30 PM KST
Regulus Therapeutics Revenue
Airrane had revenue of 6.01B KRW in the quarter ending March 31, 2025, with 57.76% growth. This brings the company's revenue in the last twelve months to 26.70B, up 65.37% year-over-year. In the year 2024, Airrane had annual revenue of 24.50B with 49.90% growth.
Revenue (ttm)
26.70B
Revenue Growth
+65.37%
P/S Ratio
5.43
Revenue / Employee
n/a
Employees
n/a
Market Cap
145.02B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 24.50B | 8.16B | 49.90% |
Dec 31, 2023 | 16.34B | 3.40B | 26.32% |
Dec 31, 2022 | 12.94B | 7.60B | 142.13% |
Dec 31, 2021 | 5.34B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition